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Abstract
Background: Purpose of this study was to deliver a report of chest CT findings of COVID-19-infected pediatric and
adult patients and to make an age-based comparison. A systematic search was conducted in accordance with PRIS
MA guidelines to identify relevant studies in the electronic databases of PubMed, Scopus, ProQuest, ScienceDirect,
and Web of Sciences from January 1, 2020 to March 27, 2020 using search terms in the titles and abstracts. Based
on our inclusion and exclusion criteria, 762 articles were screened. Finally, 15 eligible articles which had adequate
data on chest CT findings of COVID-19-infected patients were enrolled in this systematic review.
Results: In pediatric patients (15 years old or younger), peripheral distribution was found in 100% of cases, ground
glass opacities (GGO) in 55.2%, bilateral involvement in 50%, halo sign in 50%, unilateral involvement in 30%,
consolidation in 22.2%, crazy paving pattern in 20%, nodular opacities in 15%, pleural effusion in 4.2%,
lymphadenopathy in none, and normal imaging in 20.8% of cases. On the other hand, in adult patients, bilateral
involvement was reported in 76.8%, GGO in 68.4%, peripheral distribution in 62.2%, mixed GGO and consolidation
in 48.7%, consolidation in 33.7%, crazy paving pattern in 27.7%, mixed central and peripheral distribution in 25.0%,
unilateral involvement in 15.2%, nodular opacities in 9.2%, pleural effusion in 5.5%, central distribution of lesions in
5.4%, lymphadenopathy in 2.4%, and normal imaging in 9.8% of cases.
Conclusion: According to the findings of this systematic review, children infected with COVID-19 can present with
normal or atypical findings (nodular opacities/unilateral involvement) in chest imaging more frequently than adult
patients. Therefore, more caution should be taken to avoid misdiagnosis or missed diagnosis in infected children.
Besides, clinical and laboratory findings need to be considered more decision-making for pediatric patients with
normal or atypical chest CT scan but high suspicion of COVID-19.
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Background
Coronaviruses are enveloped single-stranded RNA vi-
ruses which can rapidly mutate and recombinate and
have basic reproductive number of about 2.2 [1]. Six cor-
onavirus species can result in human disease [2]. Four
species—229E, OC43, NL63, and HKU1—are prevalent
which in immunocompetent individuals typically induce
common cold symptoms [2]. The two other species—
SARS-CoV and MERS-CoV—are originally zoonotic and
occasionally have been connected to fatal illness [3]. Due
to high prevalence and wide distribution of corona-
viruses, considerable genetic diversity and frequent gen-
ome recombination, and increasing activities which
bring human and animal together, novel corona-
viruses are possible to periodically infect humans be-
cause of frequent cross-species infections and
occasional virus spillover [3, 4].
WHO (the World Health Organization) received data
on some patients with unknown cause respiratory dis-
ease from Wuhan City, China, on December 31, 2019,
with clinical presentations similar to those of viral pneu-
monia including symptoms of as fever, cough, and dys-
pnea. Also, patients often showed pulmonary opacities
at chest imaging [5]. Bronchoalveolar lavage fluid sample
analysis and electron microscopy showed coronavirus as
causative infectant, a virus with a crown like morphology
at electron microscopy resulted from viral spike peplo-
mers coming out from the viral envelope [6]. This newly
found strain has been temporarily named the 2019 novel
coronavirus (2019-nCoV or COVID-19). The virus is
highly contagious and can be transmitted from human
to human by an infected person or an asymptomatic car-
rier and is capable of spreading rapidly between cities.
Respiratory droplets are the main route of transmis-
sion, but close contact and transmission through di-
gestive tract can play a role also [7]. Most of the
cases are mild in clinical term, but the elderly or
those with comorbidities are more likely to experience
severe form of infection [8].
Humankind is generally susceptible to COVID-19 and
no vaccination or definite treatment is at hand yet. Early
detection and effective control of transmission pathways
(i.e., isolation of suspected cases, disinfection, etc.) are
still the most effective procedures to stop the COVID-19
outbreak. However, because of large number of clinically
suspected COVID-19 patients, laboratory detection tests
take a lot of time hindering early treatment and may not
be feasible for all suspected patients owing to the low
number of available COVID-19 test kits [9]. Moreover,
due to the limitation of sampling materials in the early
stage of the infection, the positive rate is relatively low
[10]. These challenges increase spread chance by free
movement of highly suspected cases who are not yet
identified and quarantined.
Imaging plays a crucial role in the diagnosis and
follow-up of novel coronavirus-infected pneumonia
(NCIP) patients. CT is regarded as preferred imaging
modality in clinically suspected cases and is valuable to
monitor imaging changes during treatment. Therefore,
CT has been considered as an effective diagnostic tool
for clinically suspected COVID-19 [9]. It potentially can
spot people with negative reverse transcription–poly-
merase chain reaction (RT-PCR) but yet highly suspi-
cious of NCIP regarding clinical conditions [10, 11]. CT
scan findings may also provide information about the
disease severity [12–15]. Furthermore, considering simi-
larities in imaging patterns of most viral pneumonia, the
CT features reported in many recent studies might be
helpful to discriminate virus from other pathogens caus-
ing pneumonia and to triage patients.
Some studies have reported CT features of patients in-
fected with COVID-19. However, chest CT findings of
pediatric patients with COVID-19 infection may be dif-
ferent from adults. In this study, we aimed to review lit-
erature systematically to find differences in reported CT
features in COVID-19-infected patients in pediatric and
adult age group, considering major CT role in screening
and triage of COVID-19 disease where there is no sero-




The present study was done according to the guidelines
of Preferred Reporting Items for a Systematic Review
and Meta-analysis (PRISMA) [16].
Search strategy
A systematic search was performed in electronic data-
bases including PubMed, Scopus, ProQuest, ScienceDir-
ect, and Web of Sciences from January 1, 2020 to March
27, 2020. The selected keywords were in accordance
with our study purpose, “Diagnostic Imaging” OR “Diag-
nostic X-Ray” OR “Diagnostic X-Ray Radiology” OR
“Medical Imaging” OR “X-Ray Computed Tomography”
OR “CT” OR “X-Ray Computer Assisted Tomography”
OR “CT X-Ray” OR “X-Ray CAT Scan” OR “X-Ray
Computerized Tomography” AND “COVID-19” OR
“2019-nCoV” OR “nCoV” OR “coronavirus” OR “SARS-
CoV-2” OR “Wuhan coronavirus” OR “Novel corona-
virus” OR “2019 novel coronavirus” OR “coronavirus
disease 2019 virus” OR “COVID-19 virus” OR “2019-
nCoV infection” OR “coronavirus disease-19.”
Eligibility criteria
After collecting the articles, their title and abstract were
evaluated and then, all eligible studies related to our
aims and with sufficient data were included in the
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present study. For exclusion criteria, we excluded (1)
posters, (2) review articles, (3) case reports, (4) letters to
the editor, (5) the articles with not comprehensive data,
and (6) not available article.
Data collection
After the first screening of the articles in accordance
with the above-mentioned keywords in their title and
abstract, the second screening was performed for finding
the relevant full-text articles based on the inclusion and
exclusion criteria and finally, the eligible articles were se-
lected. All the screening process was performed inde-
pendently by two reviewers (BF and HHA).
Results
Literature search and screening
Seven hundred sixty-two articles were found by a compre-
hensive searching on the above-mentioned electronic data-
bases and 164 duplicated articles were removed. Five
hundred ninety-eight articles were included for the first
screening, 502 articles were omitted, and 96 articles were
screened in their full texts. In the final step, 15 articles were
eligible to be included in present study which had adequate
data on chest CT findings of COVID-19-infected patients,
were in English language, and contained RT-PCR-
confirmed cases. The procedure of the literature searching
and screening method are shown in Fig. 1.
Data extraction
The data of each article including author name, number
of patients, and chest CT findings of pediatric and adult
patients infected with COVID-19 were extracted and
listed in Table 1.
Chest CT findings of pediatric patients with COVID-19
infection
In three studies [17–19] which reported CT features
in pediatric patients infected with COVID-19 (aged
15 or younger), one also included adult patients.
Ground glass opacities (GGO) frequency reported
as 60% [17], 60% [18], and 25% [19]. Consolidation
frequency reported to be 0% [17] and 50% [19], but
only one study reported mixed GGO and consolida-
tion as 0% [17]. Pleural effusion in children reported
as 0% [18] and 25% [19] and normal imaging was
seen in 20% [18] and 25% [19] of cases.
Pooling data from all studies, GGO was found in
55.2% of pediatric patients, consolidation in 22.2%,
normal imaging in 20.8%, and pleural effusion in
4.2% of cases. Lymphadenopathy frequency was re-
ported in a study by Liu et al. [19] as 0%. Xia et al.
reported halo sign in 50% of pediatric age group,
nodular opacities in 15%, crazy paving in 20%, and
peripheral distribution (subpleural lesions) in 100%
of cases [18].
Fig. 1 PRISMA flowchart used for the study selection
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Chest CT findings of adult patients with COVID-19
infection
GGO, consolidation, and mixed density frequency were
in a wide range in literature (27.3 to 80% [6, 10, 15, 19–
24, 27], 0 to 55% [6, 10, 15, 19–22, 24, 27], and 29 to
61% [6, 10, 15, 19, 20, 24, 27] of cases, respectively).
Also, considerable diversity in reported frequencies of
nodular opacities and crazy paving pattern were noted
(0 to 10% [6, 20, 23, 27] and 10 to 75% [6, 15, 19–21,
23], respectively). Lymphadenopathy (0 to 6% [6, 15, 19,
21–23, 27]), pleural effusion (0 to 23% [6, 15, 19, 21–24,
27]), unilateral involvement (0 to 25% [6, 10, 15, 19, 22,
27]), central distribution (0 to 20% [6, 10, 15, 19, 22,
27]), and normal imaging (0 to 23% [6, 15, 19, 21, 22,
27]) were less frequent features, as opposed to bilateral
involvement (59 to 100% [6, 10, 12, 15, 19, 21–27]) and
peripheral distribution (26 to 100% [6, 10, 15, 19–21, 23,
27]) which was higher than central distribution fre-
quency in corresponding study in all of cases, which
were more encountered.
Pooling data from all studies, bilateral involvement
was reported in 76.8% of adult patients, GGO in 68.4%,
peripheral distribution in 62.2%, mixed GGO and con-
solidation in 48.7%, consolidation in 33.7%, crazy paving
pattern in 27.7%, mixed central and peripheral distribu-
tion in 25.0%, unilateral involvement in 15.2%, nodular
opacities in 9.2%, pleural effusion in 5.5%, central distri-
bution of lesions in 5.4%, and lymphadenopathy in 2.4%
of patients. A total of 9.8% of adult patients had normal
imaging.
Discussion
Normal imaging was reported more frequently in in-
fected children comparing to adults (20.8% versus
6.7%). Most frequent CT feature for pediatric patients
was peripheral distribution and with decreasing order
of frequency next features were GGO, bilateral in-
volvement, unilateral involvement, consolidation, crazy
paving pattern, nodular opacities, pleural effusion,
central distribution, lymphadenopathy, and mixed
consolidation and GGO (three latter features were
not seen in any of investigated patients). Most fre-
quent CT feature for adult patients was bilateral in-
volvement and with decreasing order of frequency
next features were GGO, peripheral involvement,
mixed GGO and consolidation, consolidation, crazy
paving pattern, mixed central and peripheral distribu-
tion, unilateral involvement, nodular opacities, pleural
effusion, central distribution, and lymphadenopathy.
Hereby, CT findings reported in the studies on both
pediatric and adult cases enlisted above are discussed
and compared (this list will not include CT features
not reported in pediatric patient studies.).
GGO and consolidation
GGO is a hazy gray (slightly increased density) area
without bronchovascular obscuration, causing by partial
air displacement resulting from two possible mechanism,
alveoli partial filling or interstitial thickening [28]. Post-
mortem biopsy in a COVID-19 patient showed pulmon-
ary edema and hyaline membrane formation in both
lungs [29], which can be pathologic explain of GGO
[30]. Moreover, as mentioned above, there was diversity
in results from different studies regarding lesion density
frequency. This could be explained by symptom onset
to CT scan interval. Patients with longer time interval
between symptom onset and CT scan will have more
consolidative lesions [15]. Lesion density gradually in-
creased to consolidation in up to 2 weeks after disease
onset in a study by Pan et al. [31], which is in
consistency with a study by Shi et al. which showed
that GGO can progress to or co-existed with consoli-
dations within 1–3 weeks [23].
Consolidation reflects alveolar air occupied by fluids,
cells, or tissues and manifest as density higher than
GGO, high enough for bronchovascular obscuration
[28]. Cellular fibromyxoid exudates in alveoli may play a
role in consolidative lesions in COVID-19 [29]. For con-
solidation and mixed density, data available for children
are from two studies with small sample size [8, 19] and
further studies are needed to compare these CT findings
in adults and children.
But generally, GGO, consolidation, and mixed GGO
and consolidation all seem to occur with less prevalence
in pediatric patients.
Halo sign
Halo sign is consolidative nodule or masse with periph-
eral ground glass opacity [28] (Fig. 2). It can be associ-
ated with viral infections and organizing pneumonia
Fig. 2 Halo sign: ill-defined focus of consolidation (black arrow) is
surrounded by a rim of GGO (black arrow). Various entities can give
a halo sign; hence, it is rather a nonspecific sign
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[32]. Halo sign frequency was reported as 50% in
pediatric patients [18] and is claimed to be uncommon
in adults [33] and just mentioned in a case report [29]
and a case series with 3 cases [34].
Nodular opacities
Nodule is defined as well or poor demarcated rounded
or irregular opacity with diameter less than 3 cm [28]
(Fig. 3) which is frequently associated with viral pneu-
monia [35]. Its frequency in infected children was
slightly higher than adult patients (15% versus 9.2%).
Again, only one study has reported nodular opacity fre-
quency in children [18].
Septal thickening and crazy paving
Reticular opacities (interlobular and intralobular septal
thickening) might be at least partly due to interstitial
lymphocyte infiltration [29]. Reticular opacity pattern
frequency increases in later stage of COVID-19 patients
[23]. To our knowledge, no paper has investigated re-
ticular pattern in children, but in adults it has been re-
ported in some studies as 33% in Shi et al. study [23]
and 67% in Song et al. study [15].
If reticular opacity superimposes on GGO background,
it looks like paving stones hence so called crazy paving
pattern [28] (Fig. 4). Pathologic explain for this can be
alveolar edema and interstitial inflammation due to
acute lung injury [11, 36]. It can herald infection enter-
ing progressive or peak stage [31]. Crazy paving preva-
lence is reported as 20% in children [18] which is
slightly less frequent than that of adult patients (27.7%).
More studies with larger sample size are needed for chil-
dren to provide a more presentative frequency. Also,
studies on adults which take time interval between
symptom onset and CT scan into consideration will
troubleshoot diversities in reported prevalence.
Lymphadenopathy
Short axis diameter of 1 cm for mediastinal nodes is
considered as thresholds discriminating enlarged nodes
(lymphadenopathy based on size criterion) from normal
size nodes [28]. Lymphadenopathy is one of significant
risk factors of severe/critical COVID-19 pneumonia [37].
If lymphadenopathy coincides with pleural effusion and
numerous lung nodules, it may suggest bacterial super-
infection [13]. Lymphadenopathy is rare in both children
and adults, but only one study on pediatric patients re-
ported it with 4 cases, and none of them had lymph-
adenopathy [19].
Fig. 3 Nodular opacities: small and round, ill-defined nodules of soft tissue density (some indicated with arrows) in 3 different patients with
RT-PCR-confirmed COVID-19
Fig. 4 Crazy paving: thickened interlobular septa (hued blue in
enhanced insert) on a GGO background (highlighted in yellow)
creates similar appearance to a pavement made up of disorganized
paving stones. Colored in black and red are air bronchogram and
pulmonary vessels
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Pleural effusion
Pleural effusion is less frequent comparing to pleural
thickening and occurred in 5% of adult cases in Shi
et al. study [23]. Pleural effusion can be an indicator
of poor prognosis in NCIP [23]. An autopsy report by
Xi Liu et al. showed pleural thickening and extensive
adhesion in an adult patient with COVID-19 which is
what that is seen as pleural thickening with or with-
out visible pleural effusion in CT scan [38]. Pleural
effusion was rare in both children and adults (4.2%
and 3.5% respectively).
Bilateral involvement
Unlike SARS and MERS, where initial chest imaging
abnormalities are more frequently unilateral, COVID-
19 is more likely to involve both lungs on initial im-
aging [39]. In a systematic review by Salehi et al., bi-
lateral involvement in 919 cases was reported as
87.5% [33]. Although bilateral involvement was more
frequent in both adults and pediatric patients, but
unilateral involvement was more frequent in children
comparing to adults (30% versus 11.7%). Lieu et al.
reported bilateral involvement in 20% (1/5) of
pediatric patients, which again emphasizes on trend
toward unilaterality of lesions in pediatric patients
[40] {Liu, 2020 #2}.
Axial distribution
In several studies, it has been stated that peripheral (sub-
pleural) distribution is typical for NCIP (Fig. 5). Salehi
et al. reported 76% peripheral distribution in 121 pa-
tients (enrolled in 12 studies) [33]. In children, periph-
eral distribution frequency was 100% (yet more
prevalent than infected adults), although this difference
can be under influence of relatively small sample size in
only study which reported it [18].
Vascular enlargement, reticular opacities, air-bubble
sign (which was described in one study by Heng
et al. [30]) or lucencies and cavities in opacified areas,
air bronchogram, reverse halo (atoll) sign, craniocau-
dal distribution (upper/middle or lower zone involve-
ment), and one to five lung lobes’ involvement
frequency (and frequency of two or more lobes’ in-
volvement) are features investigated in several adult
studies, but no pediatric patients’ study has been done
to assess this finding prevalence yet; hence, as an in-
teresting issue in future studies, assessment of the
above-mentioned CT features in pediatric patients is
suggested. This study has its limitations to be noted.
First, number and sample size of pediatric patient
studies was small and this can influence on imaging
features’ prevalence; hence, we suggest more studies
with larger sample sizes to be conducted on pediatric
age group with NCIP for one can compare them with
infected adults’ chest imaging features. Second, time
gap between symptom onset and CT can influence on
prevalence of findings mentioned above, regarding
any CT feature time course. Categorizing CT findings
in predetermined time line stages would provide more
reliable frequencies and comparisons.
Conclusion
In conclusion, children infected with COVID-19 can
present with normal or atypical findings (nodular opaci-
ties/unilateral involvement) in chest imaging more than
adult patients; therefore, more caution should be taken
to avoid misdiagnosis or missed diagnosis in infected
children, and clinical and laboratory findings need to be
considered more decision-making for pediatric cases
with normal or atypical chest CT scan but highly suspi-
cious of COVID-19.
Fig. 5 Peripheral distribution: COVID-19-related pneumonia is presented as peripheral lesions in most of cases. Peripheral distribution is even
more encountered in pediatric patients
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